News
SYLOGENT COMPLETES ACQUISITION OF PEERVIEW
July 14, 2009
Newtown, PA, - July 14, 2009 — Sylogent today announced that it has completed its acquisition of PeerView, Inc. This asset acquisition agreement brings to Sylogent the market-leading publication planning solutions PubSTRAT™ and the innovative VCTR™ clinical registry solution.
As a result of the transaction Sylogent has relocated its headquarters to the historic Stocking Works in Newtown, PA, and will maintain its satellite office in Somerville, MA. Most key PeerView staff joined Sylogent, thus ensuring minimal disruption to the broad and long-standing customer relationships.
The PubSTRAT™ Web Suite™, comprising Conference Authority™, Journal Selector™, PubSTRAT™, and PubSTRAT™ CiteCentral™ is a leading publication planning solution that is in regular use by a growing number of customers in the pharmaceutical and biotech industries.
VCTR™ is rapidly emerging as the leading platform to support compliance with the increasingly complex clinical data disclosure process for biotech and pharmaceutical companies. Clinical data disclosure includes the timely registration and updating of clinical trials information as well as the posting of trial results to publicly accessible websites. The VCTR platform enables customers to significantly reduce the burden of maintaining large and complex clinical development programs in full compliance with the ever-changing US and International regulations.
“We are excited to welcome our new colleagues to Sylogent and to bring add the PeerView products and services to our offerings,” stated Jack Yeager, CEO and Founder of Sylogent. He continued, “The addition of PeerView is seen as critical to the planned growth of Sylogent, both organically and through strategic acquisitions.”
Sylogent is focused on providing workflow solutions and services that support the late clinical development and early commercialization business processes of our pharmaceutical and biotech customers.
SYLOGENT EXHIBITS AT DIA CONFERENCE
DIA's 3rd Annual Clinical Trial Disclosure Workshop
October 6-8, National Harbor, MD
OVERVIEW
How to Achieve Successful Registries and Results Databanks
Take your clinical trial disclosure processes to the next level!
Engage in interactive discussions
with government, biopharmaceutical, medical device, and data standards experts on
how to ensure compliance and improve efficiency in clinical trial disclosure.
FEATURED TOPICS
Global Requirements, Laws, Regulations and Business Cases
Defining the Clinical Trial Disclosure Role within a Company
Available Tools, Resources, Organizations
Impact of External Stakeholders, Company Policies, and Advanced Technologies on
Disclosure Processes
Key Milestones for Managing Compliance
Quality Checks
Lessons Learned
LEARNING OBJECTIVES:
Discuss global clinical trial registry requirements;
Identify skill sets necessary to be successful in a clinical trial disclosure role;
Discuss the various resources (internal/external) currently available to help with clinical trial disclosure;
Identify a clinical trial disclosure process for ensuring compliance for their company; and
Discuss how to communicate and implement corporate clinical trial disclosure changes
TARGET AUDIENCE:
Professionals with a working knowledge of clinical trial registries and the disclosure process
Clinical trial leaders
Medical communications groups
Independent investigators
Biotechnology researchers
Pharmaceutical/medical device/academic clinical investigators
Regulatory affairs personnel
Quality assurance professionals
Investigator site personnel
Health policy professionals